InvestorsHub Logo
Followers 29
Posts 940
Boards Moderated 0
Alias Born 03/10/2014

Re: shurtha2000 post# 277

Thursday, 12/28/2017 12:17:01 PM

Thursday, December 28, 2017 12:17:01 PM

Post# of 675
Looking very promising here!
I would guess based on the last PR, they will conduct another Phase 3 specifically directed at the subgroups, or maybe the FDA provided Guidance that they can continue to file for Acceptance based on the data of the subgroups alone. Regardless of the primary endpoints not being met, the subgroups performed amazingly!
Here's to looking for a golden 2018!
Best Of Luck!
IMHO

In My Own Personal Opinion Of Course!